导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 34.91% | 381/4982 |
| 近一周 | -1.31% | 942/5419 |
| 近一月 | -4.43% | 2616/5423 |
| 近一季 | -14.52% | 3813/5358 |
| 近半年 | 24.50% | 424/5131 |
| 近一年 | 53.19% | 251/4733 |
| 近两年 | 157.80% | 351/4208 |
| 近三年 | 135.41% | 220/3661 |
| 成立以来 | 69.80% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.32% 1087/5130 |
75.60% 484/5464 |
- - |
- - |
| 2025 | 73.15% 263/5130 |
4.86% 1824/4624 |
1.37% 2669/4802 |
53.22% 312/4970 |
6.31% 459/5130 |
| 2024 | 2.14% 2241/4618 |
-0.34% 1482/4340 |
4.64% 392/4442 |
4.11% 3924/4550 |
-5.93% 3438/4618 |
| 2023 | -20.82% 2739/4216 |
-5.36% 3306/3759 |
-3.12% 1494/3909 |
-10.62% 2672/4055 |
-3.38% 1440/4209 |
| 2022 | -24.03% 1685/3578 |
-12.63% 551/2804 |
4.66% 2103/3205 |
-13.88% 2075/3430 |
-3.53% 2303/3570 |
| 2021 | 20.15% 328/2717 |
-9.54% 1424/1745 |
20.92% 307/2232 |
15.14% 121/2560 |
-4.60% 2102/2708 |
| 2020 | 56.58% 501/1596 |
-1.92% 537/1036 |
32.29% 187/1256 |
-1.18% 1192/1472 |
22.11% 204/1690 |
| 2019 | 52.63% 208/926 |
31.97% 324/3053 |
-0.59% 1610/3201 |
8.02% 328/939 |
7.70% 572/1014 |
| 2018 | -25.65% 331/668 |
- - |
-3.61% 1490/2983 |
-8.74% 2438/2970 |
-12.31% 2400/2975 |
| 2017 | 28.49% 74/531 |
- - |
- - |
- - |
- - |
| 2016 | -26.64% 379/455 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 1.0027 | 54.69% |
| 招商创新增长混合A | 1.0759 | 54.25% |
| 招商创新增长混合C | 1.0235 | 53.96% |
| 华泰柏瑞医疗健康A | 2.6422 | 49.29% |
| 华泰柏瑞医疗健康C | 2.5804 | 49.15% |
| 招商品质成长混合A | 1.0435 | 49.15% |
| 大摩优悦安和混合A | 0.8994 | 47.23% |
| 大摩优悦安和混合C | 0.8828 | 47.08% |
| 中信建投医药健康A | 0.7950 | 39.62% |
| 大摩健康产业混合A | 1.9440 | 32.70% |
| 宏利蓝筹混合 VS. 长安宏观策略混合A(740001) |